573 related articles for article (PubMed ID: 18313663)
1. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
2. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
3. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Jul; 567(1-2):125-30. PubMed ID: 17498686
[TBL] [Abstract][Full Text] [Related]
4. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
5. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
[TBL] [Abstract][Full Text] [Related]
6. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
Cichewicz DL; McCarthy EA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1010-5. PubMed ID: 12604676
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
9. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
Pugh G; Smith PB; Dombrowski DS; Welch SP
J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
Welch SP; Thomas C; Patrick GS
J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346
[TBL] [Abstract][Full Text] [Related]
11. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
[TBL] [Abstract][Full Text] [Related]
12. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
13. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
Terner JM; Barrett AC; Lomas LM; Negus SS; Picker MJ
Pain; 2006 May; 122(1-2):90-101. PubMed ID: 16527399
[TBL] [Abstract][Full Text] [Related]
14. Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents.
Khroyan TV; Polgar WE; Orduna J; Zaveri NT; Judd AK; Tuttle DJ; Sanchez A; Toll L
Eur J Pharmacol; 2007 Mar; 560(1):29-35. PubMed ID: 17303110
[TBL] [Abstract][Full Text] [Related]
15. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine.
Cichewicz DL; Haller VL; Welch SP
J Pharmacol Exp Ther; 2001 Apr; 297(1):121-7. PubMed ID: 11259535
[TBL] [Abstract][Full Text] [Related]
16. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
[TBL] [Abstract][Full Text] [Related]
17. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Christoph T; De Vry J; Tzschentke TM
Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.
Cichewicz DL; Welch SP; Smith FL
Eur J Pharmacol; 2005 Nov; 525(1-3):74-82. PubMed ID: 16288738
[TBL] [Abstract][Full Text] [Related]
19. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
Wakley AA; Craft RM
Behav Pharmacol; 2011 Sep; 22(5-6):489-97. PubMed ID: 21716095
[TBL] [Abstract][Full Text] [Related]
20. Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast.
Lilius TO; Rauhala PV; Kambur O; Kalso EA
Anesthesiology; 2009 Dec; 111(6):1356-64. PubMed ID: 19934882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]